DocStoX is a free AI-powered research platform for Indian equity markets, covering 6,800+ NSE & BSE stocks with prices, fundamentals, 326 financial ratios, shareholding, FII/DII flows, F&O, IPOs, a visual screener and AI stock scoring.

Yes. DocStoX has a free tier covering stock research, the screener, FII/DII data and educational guides, plus a free MCP API tier (50 tool calls/day) for AI assistants. A Pro plan adds higher limits and advanced features.

What data does DocStoX cover?

Every NSE & BSE listed stock (6,800+ instruments): EOD and intraday prices, income statement / balance sheet / cash flow, 326 ratios, quarterly shareholding, promoter pledge, mutual-fund holdings, FII/DII flows, F&O and option-chain data, analyst forecasts, IPOs, corporate actions and news.

Can AI assistants like ChatGPT or Claude use DocStoX data?

Yes. DocStoX runs a public Model Context Protocol (MCP) server at https://mcp.docstox.com/mcp with 39 tools, so Claude, ChatGPT, Cursor and other MCP clients can pull Indian market data directly. Setup and a free key are at https://docstox.com/mcp.

All news

Neutral impactCompany

Sun Pharma Share Price Live Updates: Sun Pharma's Market Movement

Economic Times 4 hrs ago·31 Jul 2026, 3:00 am

Sun Pharma shares are currently in focus as the stock market tracks the company's performance. Investors are closely monitoring the daily price movements to gauge the company's current market position and investor sentiment.

This news matters to investors because the stock's volatility can indicate broader trends in the pharmaceutical sector. Traders are watching for key support and resistance levels to understand potential short-term price action.

What to watch next includes the overall market breadth and any specific volume spikes in Sun Pharma. Keeping an eye on sector peers will also provide context for the stock's recent direction.